InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases. Founded in 2020, Innoskel is backed by investors that include Vida Ventures, Jeito Capital, Turenne Capital, and Region Sud Investissement and is headquartered in Valbonne.